Meeting/Workshop
The beginning and end of schizophrenia : does neuropsychiatry terminate the era of schizophrenia?
November 27, 2017
Freiburg (Germany)
INTRODUCTION
There is an increasing awareness of the fact, that the ICD- and DSM-based nosological concepts in general psychiatry are insufficient not only for research purposes but also from a clinical diagnostic and therapeutic perspective. Presently, DSM-ord ICD-based psychiatric diagnoses generally represent umbrella terms focusing on patterns of phenotypical psychopathological presentations of different neuropsychiatric disorders rather than on neurophysiological pathomechanisms or etiologies. The concept of neuropsychiatry stands for a reform of psychiatric classification in which causal i.e. neuropsychiatric elements play a more important role in diagnosing and treating patients with different psychiatric syndromes. The implementation of an etiology based-diagnostic and therapeutic process could have revolutionizing consequences on psychiatry where disease classification presently is almost free of causal thinking.
In this symposium we will illustrate this rapidly evolving process based on different areas of research in which relevant progress is obvious over the last decade focusing on the classical disorder of psychiatry: schizophrenia.
In a joint controversy debate, the pros and cons of the term and concept of schizophrenia will discuss in depth the pitfalls of psychiatric and their relevant implications for research.
PROGRAM
Welcome & Introduction
9:00 9:15 Ludger Tebartz van Elst (Clinic for Psychiatry & Psychotherapy, A.L. University of Freiburg, Germany )
9:15 9:30 Katharina Domschke (Clinic for Psychiatry & Psychotherapy, A.L. University of Freiburg )
SESSION 1 Secondary or symptomatic forms of schizophreniform syndromes
Chaired by K.D. Domschke & S. Heckers
9:30 10:00 Michael R. Trimble (Institute of Neurology, London, UK)
The history of the neuropsychiatry of schizophrenia: where do we come from?
10:00 10:30 Olivier Bonnot (Centre Hospitalier, Université de Nantes, France)
Schizophreniform disorders secondary to treatable metabolic diseases
10:30 11:00 Ludger Tebartz van Elst (Clinic for Psychiatry & Psychotherapy, A.L. University of Freiburg, Germany )
Epilepsy or schizophrenia: on the link between the two entities
11:00 11:30 Coffee Break
11:30 12:00 Angela Vincent (University of Oxford, Oxford, UK)
Autoimmune disorder or schizophrenia: a critical analysis of antibody findings in schizophrenia
12:00 12:30 James Walters (Cardiff University School of Medicine, Cardiff, UK)
The genetics of schizophrenia
12:30 14:00 Lunch break
SESSION 2 Primary idiopathic or multigenetic variants of schizophreniform syndromes
Chaired by L. Tebartz van Elst & M. Trimble
14:00 14:30 Jack Foucher (University of Strasbourg & CEP, France)
How looking at differences rather than commonalities reveals 35 consistent psychotic phenotypes: Reconsidering the Wernicke-Kleist-Leonhardt School
14:30 15:00 Jim van Os (Maastricht University Medical Centre, Maastricht, Netherlands)
The epidemiology of schizophreniform symptoms in the general population
15:00 15:30 Stephan H. Heckers (Vanderbilt University, TN, USA)
How can we make progress in schizophrenia research?
15:30 16:00 Coffee Break
This meeting is associated to a controversy debate that will follow the current event. (16h-17h30, same day, same venue)
DATES AND VENUE
Monday, the 27th of November 2017.
Haus zur Lieben Hand
Löwenstraße 16, Freiburg i.Br.
PLEASE NOTE THAT...
This meeting is associated to a controversy debate that will follow the current event. (16h-17h30, same day, same venue)